Shanghai Kaibao Pharmaceutical CO.,Ltd (SHE:300039)

China · Delayed Price · Currency is CNY

4.520

+0.050 (1.12%)

Jul 3, 2026, 3:04 PM CST

-26.74% (1Y)

Market Cap	4.73B -27.1%
Revenue (ttm)	1.04B -26.0%
Net Income	259.16M -30.2%
EPS	0.25 -30.2%
Shares Out	1.05B
PE Ratio	18.25
Forward PE	n/a
Dividend	0.20 (4.42%)
Ex-Dividend Date	May 29, 2026

Volume	15,501,028
Open	4.160
Previous Close	4.470
Day's Range	4.160 - 4.560
52-Week Range	4.020 - 7.030
Beta	0.24
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 25, 2026

About SHE:300039

Shanghai Kaibao Pharmaceutical CO.,Ltd engages in the research, development, production, and sale of modern traditional Chinese medicines primarily in China. The company offers heat-clearing and detoxifying products, such as Tanreqing Injection for wind-heat in the lungs with phlegm-heat obstructing the lungs, early-stage pneumonia, acute bronchitis, acute exacerbations of chronic bronchitis, and respiratory infections; and Phlegm-Heat Clearing Capsules to clear heat, resolve phlegm, and detoxifying. It also provides liver-protecting products, ... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 2000

Employees 1,197

Stock Exchange Shenzhen Stock Exchange

Ticker Symbol 300039

Full Company Profile

Financial Performance

In 2025, SHE:300039's revenue was 1.15 billion, a decrease of -21.76% compared to the previous year's 1.47 billion. Earnings were 278.58 million, a decrease of -25.83%.

Financial Statements